# Rifampin-combined Antibiotic Therapy for Staphylococcal PJI

> **NCT07313215** · NA · RECRUITING · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 428 (estimated)

## Conditions studied

- Periprosthetic Joint Infection

## Interventions

- **DRUG:** Rifampicin (R)

## Key facts

- **NCT ID:** NCT07313215
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-13
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-18
- **Target enrollment:** 428 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313215, "Rifampin-combined Antibiotic Therapy for Staphylococcal PJI". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07313215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*